Z-2388-2018 Class II Terminated

Recalled by GE Medical Systems, SCS — Buc

FDA device recall Z-2388-2018 was initiated by GE Medical Systems, SCS on Mar 29, 2018 and is designated Class II. Reason for recall: The Discovery IGS and Innova IGS systems may experience X-ray abort errors which could result in the loss of imaging mode before or during fluoroscopic use. The recall status is terminated (terminated Jun 15, 2021). Affected quantity: 102 devices total.

Recall details

Product Type
Devices
Report Date
Jul 18, 2018
Initiation Date
Mar 29, 2018
Termination Date
Jun 15, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
102 devices total

Product description

Discovery IGS 740 Interventional Fluoroscopic X-ray Systems

Reason for recall

The Discovery IGS and Innova IGS systems may experience X-ray abort errors which could result in the loss of imaging mode before or during fluoroscopic use.

Distribution pattern

US distribution: AR, CA, CA, FL, GA, IA, IL, NC, NH, NJ, NM, NY, PA, SC, TN, A,WI, WV. International Distribution: Argentina, Brazil, China, Colombia, Egypt, France, India, Indonesia, Iran, Italy, Japan, Kuwait, Lithuania, Myanmar, Palestine, Poland, Russia, Saudi Arabia, Singapore, Spain, Tunisia, Turkey, United Kingdom, Vietnam.

Code information

Model Number 5730891- Lot Number (System ID): 00000D4-17-029 (478765NSP), 00000D4-17-031 (712279DIS), 00000D4-17-030 (716845DISC), 00000D4-18-003 (951TVHDISC740), 00000D4-18-001 (352751DISC), 00000D4-17-032 (SA1011VA02); Model Number 5759342 - 00000D4-17-028 (GON 4610398).

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2388-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2388-2018. Report a data issue: hello@regdatalab.com.